Kareem O Kafilat¹*, Aina O Oluwagbemiga¹, Enwuru A Christian², Awoderu B Oluwatoyin² and Bamgbose J Damilare¹

¹Biochemistry and Nutrition Department, Nigerian Institute of Medical Research, Nigeria
²Center for Infectious Disease Research Laboratory, Nigerian Institute of Medical Research, Nigeria

*Corresponding Author: Kareem O Kafilat, Biochemistry and Nutrition Department, Nigerian Institute of Medical Research, Nigeria.

Received: September 19, 2022; Published: October 04, 2022

Abstract

New Zealand White rabbits were presented with corneal opacity and watery discharge from the eyes. Repeat syndromic management using antimicrobial treatment with gentamicin did not lead to clinical improvement. Using standard protocols, a definitive diagnosis was made with microbiological culture and antibiogram at the Center for Infectious Disease Research laboratory. Biochemical analysis revealed Pseudomonas aeruginosa as the etiologic agent, and it has been reported as a common organism associated with bacterial keratitis. The antibiotic susceptibility tests showed sensitivity to piperacillin, ceftazidime, and imipenem, which are recommended choices for Pseudomonas. However, the animals were subjected to a second-line antibiotic (Ciprofloxacin) treatment for 7 days, and by the 5^th day, the symptoms were relieved. A hematological examination showed neutropenia and lymphopenia. The findings of this report underscore the need for microbial isolation, identification, and susceptibility testing before the medical armamentarium.

Keywords: Corneal Infection; Rabbits; Pseudomonas Aeruginosa

References

1. Gray LD and Kreger AS. “Rabbit corneal damage produced by Pseudomonas aeruginosa infection”. Infection and Immunity2 (1975): 419-432.
2. Hancock RE and Speert DP. “Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment”. Drug Resistance Updates4 (2000): 247-255.
3. Preston MJ., et al. “Contribution of proteases and LasR to the virulence of Pseudomonas aeruginosa during corneal infections”. Infection and Immunity8 (1997): 3086-3090.
4. Alionte LG., et al. “Pseudomonas aeruginosa LasA protease and corneal infections”. Current Eye Research4 (2001): 266-271.
5. Hobden JA. “Pseudomonas aeruginosa proteases and corneal virulence”. DNA and Cell Biology5-6 (2002): 391-396.
6. Clinical Laboratory Standard Institute (CLSI) 30^th Performance Standards of Antimicrobial Susceptibility Testing (2020).
7. Benson KG and Paul-Murphy J. “Clinical pathology of the domestic rabbit: acquisition and interpretation of samples”. Veterinary Clinics of North America: Exotic Animal Practice3 (1999): 539-551.
8. Garg P., et al. “Ciprofloxacin-resistant Pseudomonas keratitis”. Ophthalmology7 (1999): 1319-1323.
9. Lomholt JA., et al. “Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors”. Infection and Immunity10 (2001): 6284-6295.
10. Vazirani J., et al. “Multidrug-resistant Pseudomonas aeruginosa keratitis: risk factors, clinical characteristics, and outcomes”. Ophthalmology10 (2015): 2110-2114.
11. Saeed A., et al. “Risk factors, microbiological findings, and clinical outcomes in cases of microbial keratitis admitted to a tertiary referral center in Ireland”. Cornea3 (2009): 285-292.
12. Bodey GP., et al. “Infections caused by Pseudomonas aeruginosa”. Reviews of Infectious Diseases 2 (1983): 279-313.
13. Peyman GA., et al. “Postoperative endophthalmitis: a comparison of methods for treatment and prophylaxis with gentamicin”. Ophthalmology Surgery 1 (1975): 45-55.
14. Melillo A. “Rabbit clinical pathology”. Journal of Exotic Pet Medicine3 (2007): 135-145.

Citation

Citation: Kareem O Kafilat., et al. “Corneal Infection in Rabbits Caused by Pseudomonas Aeruginosa: A Case Report". Acta Scientific Veterinary Sciences 4.11 (2022): 06-11.

Copyright

Copyright: © 2022 Kareem O Kafilat., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.